Farmacéuticos Comunitarios. 2014 Jun 30; 6(2):11-19 DOI: 10.5672/FC.2173-9218.(2014/Vol6).002.03

Influence of pharmaceutical care services on cardiovascular risk factors, retention and patient satisfaction in community pharmacy (FISFTES Project)

Bofí Martínez P1, García-Jiménez E2
1. Licenciada en Farmacia. Farmacéutica comunitaria en Playa de Miramar (Valencia) 2. Doctor en Farmacia. Farmacéutico comunitario en Huécija (Almería). CEO Melpopharma. Miembro del Grupo de Investigación en Atención Farmacéutica de la Universidad de Granada (España).
Bofí P, García-Jiménez E. Influencia de los servicios de atención farmacéutica sobre los factores de riesgo cardiovascular, fidelización y satisfacción de los pacientes en la farmacia comunitaria (Proyecto FISFTES). Farmacéuticos Comunitarios. 2014 Jun 30; 6 (2): 11-19 DOI: 10.5672/FC.2173-9218.(2014/Vol6).002.03
Abstract : 

Aim: To analyse the effects of health education (HE) and drug therapy monitoring (DTM) services on modifiable cardiovascular risk factors (CVRF) and cardiovascular risk (CVR, SCORE) in patients attending a community pharmacy, and to assess levels of patient loyalty and satisfaction with the services provided.

Material and methods: Randomized experimental longitudinal study in 2 groups: health education group (HEG)/drug therapy monitoring group (DTMG) conducted in 11 community pharmacies in Spain between April and December 2011 in patients aged 18-85 with 1 or more CVRF.

Variables studied: CVR (SCORE), modifiable CVRF, loyalty, satisfaction.

Results: Of the 79 patients enrolled, 72 completed the study (36 HEG, 36 DTMG). The proportion of patients with a low cardiovascular risk (SCORE) remained stable at 36.0 % in HEG, but increased from 47.0 % to 53.0 % in DTMG. There was an 11.0 % decrease in the number of patients with a high cardiovascular risk in HEG and a 6.0 % decrease in DTMG. A high loyalty score was maintained in 92.3 % of patients and the number of patients with a low loyalty score was reduced from 7.7 % to 3.8 %. 65.5 % of patients would pay for the HE service and 86.4 % would pay for the DTM service.

Conclusions: Both services improved patient CVR, although DTM achieved 6 % more patients with mild CVR, leading to patients becoming loyal to a particular community pharmacy.  After 6 months, 7 in 10 patients would pay for the HE service and 9 in 10 would pay for the DTM service.

Article download link: